Dr Emmanuel ChatelusRhumatologue à Strasbourg

2024La Revue de medecine internePubMed

French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseases

2022Annals of the rheumatic diseasesPubMed

Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016-2017

2022Joint bone spinePubMed

Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritides

2022Annals of the rheumatic diseasesPubMed

B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics

2021Rheumatology (Oxford, England)PubMed

Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases

2021Infectious diseases and therapyPubMed

Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection

2021The Lancet. RheumatologyPubMed

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases

2020Joint bone spinePubMed

How and why are rheumatologists relevant to COVID-19?

2019Joint bone spinePubMed

Single tumor-like tophus

2017The Journal of rheumatologyPubMed

Lumbar Spine Chondrocalcinosis

2025Journal of autoimmunityPubMed

Evaluation of the mycophenolate mofetil-rituximab combination in systemic sclerosis: a French retrospective multicenter study (MycRiSSc)

2022Autoimmunity reviewsPubMed

Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature

2022The Lancet. RheumatologyPubMed

Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab

2022RMD openPubMed

Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)

2021Arthritis research & therapyPubMed

Incidence and predictors of COVID-19 and flares in patients with rare autoimmune diseases: a systematic survey and serological study at a national reference center in France

2019Presse medicale (Paris, France : 1983)PubMed

[Contribution of Doppler ultrasound for the diagnosis of giant cell arteritis]

2019Autoimmunity reviewsPubMed

Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature

2022Rheumatology (Oxford, England)PubMed

Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients

2021Annals of the rheumatic diseasesPubMed

Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

2021Rheumatology (Oxford, England)PubMed

Application of the OMERACT synovitis ultrasound scoring system in juvenile idiopathic arthritis: a multicenter reliability exercise

2021Joint bone spinePubMed

Rheumatic presentations of Guillain-Barré syndrome as a diagnostic challenge: A case series

2025RMD openPubMed

METHOFRACT, a methotrexate osteopathy multicentre cohort study

2020TheranosticsPubMed

A mouse model of MSU-induced acute inflammation in vivo suggests imiquimod-dependent targeting of Il-1β as relevant therapy for gout patients

2020Seminars in arthritis and rheumatismPubMed

T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients

2022Rheumatology (Oxford, England)PubMed

Significance of Sjögren's syndrome and anti-cN1A antibody in myositis patients

2017RMD openPubMed

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients

2024Journal of clinical medicinePubMed

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

2020Autoimmunity reviewsPubMed

Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014

2026Rheumatology (Oxford, England)PubMed

Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis atlas

2022Autoimmunity reviewsPubMed

Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature

2026 · Article

Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR database

2026 · Article

Reliability of ultrasound assessment of elementary lesions in psoriatic arthritis and development of a reference dactylitis Atlas

2025 · Article

Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study

2025 · Article

Comment on: Hydroxychloroquine levels in pregnancy and materno–fetal outcomes in Systemic Lupus Erythematosus patients: Reply

2025 · Article

METHOFRACT, a methotrexate osteopathy multicentre cohort study

2024 · Article

Repurposing the Fibrosis-4 Score in Rheumatoid Arthritis: Data from the ESPOIR Cohort

2024 · Article

History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosis

2023 · Article

Heart and systemic sclerosis—findings from a national cohort study